Abivax S.A. (ABVX) income statement
ABVXNasdaqPharmaceutical PreparationsFiscal year ends December 31Also trades as AAVXF
$83.83+1.73 (+2.11%)
Close on Nov 18, 2026Market cap $6.58BP/E –Yield –
Abivax S.A. financial ratios
See a number that looks wrong?